Wellgistics Health refinances convertible debt with $21 million note, adds $6.5 million new capital

Wellgistics Health Inc

WGRX

0.00

Wellgistics Health issued a $21 million convertible debt instrument to refinance all outstanding convertible debt.
The financing raised $6.5 million in new capital for working capital and general corporate purposes.
The New Debt does not accrue interest, converts into common shares at $6 per share.
An automatic exchange would convert the New Debt into Preferred Stock once a registration statement is effective and shareholders approve the new class.
The Funding Preferred converts into common shares at $50 per share, implying potential future dilution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605271750ACCESSWRNAPR_____1171274) on May 27, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.